Syngene International Ltd SYNGENE Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

19:28 EST 14 Nov 2017 | BioPortfolio Reports


Syngene International Ltd Syngene, a subsidiary of Biocon Ltd is a contract research and manufacturing organization that provides support services for research and development programs. The organization offers drug discovery and development services such as lead generation and optimization, medicinal chemistry, toxicology, custom synthesis, in vivo pharmacology, process research and development, cGMP manufacturing, formulations and clinical development services. It serves various sectors such as pharmaceutical, animal health, biotechnology, agrochemicals, consumer health, cosmetic and nutrition companies. The organization works in partnership with global pharmaceutical and biotechnology companies to support their clinical development programs. Syngene is headquartered in Bangalore, Karnataka, India.

Syngene International Ltd Key Recent Developments

Jul 27,2017: Syngene Q1 FY18 Revenue up 6% to Rs. 308 Cr

Jul 27,2017: Syngene Annuonce the Appointment of Ms Vinita Bali as Non Executive Independent Director of the company

Jul 27,2017: Syngene International Announces Broadening of Research Collaboration with Amgen Expands Dedicated RD Center

Apr 27,2017: Syngene Delivered 14% Revenue Growth in FY17

Apr 27,2017: Syngene International Appointment of Mr. Jonathan Hunt as Whole Time Director and Mr. Peter Bains, NonExecutive Director stepped down from the Board

This comprehensive SWOT profile of Syngene International Ltd provides you an indepth strategic analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData's Profile on Demand' service, covering over 50,000 of the world's leading companies. Once purchased, GlobalData's highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Syngene International Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. excluding weekends.

The profile contains critical company information including*,

Business description A detailed description of the company's operations and business divisions.

Corporate strategy Analyst's summarization of the company's business strategy.

SWOT Analysis A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history Progression of key events associated with the company.

Major products and services A list of major products, services and brands of the company.

Key competitors A list of key competitors to the company.

Key employees A list of the key executives of the company.

Executive biographies A brief summary of the executives' employment history.

Key operational heads A list of personnel heading key departments/functions.

Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semiannual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Original Article: Syngene International Ltd SYNGENE Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300


More From BioPortfolio on "Syngene International Ltd SYNGENE Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300"

Quick Search


Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...